P40 How Did FDA Consider Patient Experience Data in Regulatory Decisions Among Approved Drugs in 2022?
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.052
https://www.valueinhealthjournal.com/article/S1098-3015(23)00152-3/fulltext
Title :
P40 How Did FDA Consider Patient Experience Data in Regulatory Decisions Among Approved Drugs in 2022?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00152-3&doi=10.1016/j.jval.2023.03.052
First page :
Section Title :
Open access? :
No
Section Order :
11853